Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

/PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a precision immunotherapy company committed to discovering and developing novel, differentiated...

Related Keywords

Mexico ,Boston ,Massachusetts ,United States ,Waltham ,Buenos Aires ,Distrito Federal ,Argentina ,Juliana Idoyaga ,Society For Immunotherapy Of Cancer ,Stanford University School Of Medicine ,National Autonomous University Of Mexico ,Baxter Foundation Faculty Scholar Award ,Biomedical Sciences ,Department Of Microbiology ,Rockefeller University ,Inclusion In Immunology Committee ,Stanford University ,Buenos Aires University ,Scientific Advisory Board ,Annual Meeting ,Scientific Advisory ,Presentation Details ,Chief Scientific Officer ,Assistant Professor ,Stanford University School ,National Autonomous University ,Cellular Physiology ,Independence Award ,New Innovator Award ,Gabilan Faculty Fellow ,Immunitas Therapeutics ,Recommended Phase ,Nc ,